Asset Details
- Identifier:
- BCP_140_f2
- Description:
- Mean free plasma concentration‐time profiles of Ro44–3888 after oral administration of sibrafiban (2 mg twice daily) alone (◆) or in combination (●) with ticlopidine (250 mg twice daily) and aspirin (80 mg twice daily) for 7 days. Data are expressedas mean±standard deviation of the mean.
- License:
- Rights Managed
- Rights Holder:
- John Wiley & Sons, Inc.
- License Rights Holder:
- Asset Type:
- Image
- Asset Subtype:
- Chart/Graph
- Image Orientation:
- Landscape
- Image Dimensions:
- 300 x 203
- Image File Size:
- 7.51 KB
- Creator:
- Bärbel Wittke,, Hilary Ensor,, Jain Chung,, Herbert Birnböck,, Berthold Lausecker,, Sylvie I. Ertel,, Ian J. Mackie, Samuel J. Machin
- Credit:
- Wittke,, B., Ensor,, H., Chung,, J., Birnböck,, H., Lausecker,, B., Ertel,, S. I., Mackie, I. J., & Machin, S. J. (2000). Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin. British Journal of Clinical Pharmacology, 49(3), 231-239. https://doi.org/10.1046/j.1365-2125.2000.049003231.x.
- Collection:
- Keywords:
- Restrictions:
- Property Release:
- No
- Model Release:
- No
- Purchasable:
- Yes
- Sensitive Materials:
- No
- Article Title:
- Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin
- Article Authors:
- Bärbel Wittke,, Hilary Ensor,, Jain Chung,, Herbert Birnböck,, Berthold Lausecker,, Sylvie I. Ertel,, Ian J. Mackie, Samuel J. Machin
- Article Copyright Year:
- 2000
- Publication Title:
- British Journal of Clinical Pharmacology
- Publication Volume:
- 49
- Publication Issue:
- 3
- Publication Date:
- 03/01/2000
- DOI:
- https://doi.org/10.1046/j.1365-2125.2000.049003231.x
Click on image to enlarge
